1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 08 DECEMBER 2014

Cancer Drug News 08 DECEMBER 2014

  • December 2014
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Rare Diseases Becoming Lucrative Targets
Industry Trend Analysis - Neratinib's Delayed Filing Shakes Confidence In Puma
Industry Brief - Milestone Triggered As EMA Accepts Application For Imbruvica In WM
Industry Brief - FDA Approves Jakafi For Polycythaemia Vera
Industry Brief - Selinexor Granted ODD In Europe For Multiple Indications
Industry Brief - Juno Licenses CAR T-Cell Product Candidate From Opus Bio
Industry Brief - Cellectar Granted FDA ODD For I-131-CLR1404 In MM
Industry Brief - Acetylon Initiates Phase II Study Of Ricolinostat In Combination With Pomalyst
Industry Brief - FDA Accepts AstraZeneca's NDA Filing For Iressa
Industry Brief - Dosing Begins In OncoMed's Tarextumab Phase II Trial For SCLC
Industry Brief - BeyondSpring To Initiate Plinabulin Phase III Trial In NSCLC
Industry Brief - EC Approves Further Indication For Xtandi
Industry Brief - Aeterna Zentaris/Sinopharm A-Think Sign Deal For Zoptarelin Doxorubicin In China
Industry Brief - Momenta's Necuparanib Gains FDA Fast Track Designation For MPC
Industry Brief - TRACON Initiates TRC105 Phase II Trial In RCC
Industry Brief - ImmunoCellular's ICT-107 Moving Towards Phase III
Industry Brief - Eisai Vies For Levatinib Approval In South Korea
Industry Brief - Tesaro/AnaptysBio Expand Immuno-Oncology Ab Collaboration
Industry Brief - FDA Places CytRx' Aldoxorubicin Trials On Partial Clinical Hold
Industry Brief - Array To Regain Global Rights To Binimetinib From Novartis
Industry Brief - Euclises/GIBH Collaborate To Accelerate Development Of Cox-2 Inhibitors
Industry Brief - Evotec/Sanofi In Talks For Multi-Component Strategic Collaboration
Industry Brief - FDA Approves Xgeva For HCM Refractory To Bisphosphonate Therapy
Industry Trend Analysis - Takeda's Oncology Rebranding To Reinforce Global Position
Industry Brief - Evgen Seeking To Raise GBP20mn In IPO On AIM
Industry Brief - CTI Earns Trisenox Milestone Payment From Teva

Table Of Contents

Cancer Drug News 08 DECEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.